Johnson & Johnson
Novel collaboration inaugurated to transform treatment for tuberculosis
A consortium of philanthropic, non-profit and private sector organisations have launched a collaboration that aims to accelerate the development of novel “pan-TB” drug regimens
Firm announces $50,000 African Innovation challenge
In line with the theme Repositioning Healthcare in Africa for Sustainable Development, global brand Johnson & Johnson has announced the second edition of Africa...
Cancer-killing viruses show promise, spur interest from drug giants
Pharmaceutical giant Johnson & Johnson announced on May 2, 208 that it would pay up to US$1 billion to acquire a company that makes cancer-killing viruses. It was a striking show of support for a still-unproven treatment, but the bid is just the latest sign that industry and academics are warming to the approach. In…
‘How science reporting can drive sustainable development goals’
Scientists gathering at the Kigali Convention Centre, Rwanda for the Next Einstein Forum (NEF), yesterday said science journalism in Africa had potentials to drive the...
Popular baby powder associated with ovarian cancer
The California jury's decision marks the largest award yet in a string of lawsuits that claim the firm did not adequately warn about cancer risks from talc-based products.